Solid IO Revenue

Hospitals and Health Care • Solid Immuno-Oncology Oy, C/O Terkko Health Hub, Finland • 1-10 Employees

Solid IO revenue & valuation

Annual revenue	$684,440
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Hospitals and Health Care industry and current estimated revenues	$2,200,000
Total funding	$841,600

Key Contacts at Solid IO

Heidi Haikala

Co-Founder & Chief Scientific Officer Cso

Noora Hujala

Ceo, Co-Founder

Lasse Leino

Chairman Of The Board Of Directors

Company overview

Headquarters	Solid Immuno-Oncology Oy, C/O Terkko Health Hub, Haartmaninkatu 4, Building 14, Helsinki, 00290 , FI
Website	solid-io.com
NAICS	62
Founded	2025
Employees	1-10

Solid IO Email Formats

Solid IO uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@solid-io.com), used 66.7% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@solid-io.com	66.7%
{first name}.{last name}	john.doe@solid-io.com	33.3%

About Solid IO

At Solid IO, we are transforming oncology and immunotherapy with organ-on-chip technology. Our patient-specific tumor models provide real-time, biologically relevant data, empowering oncologists, researchers, and pharmaceutical innovators to make precise, informed treatment decisions. By replicating the tumor microenvironment, our platform eliminates uncertainty, accelerating drug development, optimizing clinical trials, and expanding access to advanced cancer therapies. With Solid IO, the next era of precision oncology begins now. ➡️ Advancing immuno-oncology research ➡️ Bridging science & clinical application ➡️ Optimizing drug development & patient outcomes WHY SOLID IO? ✅ Real-time patient-specific insights – Predict treatment responses before and during therapy. ✅ Faster, more efficient drug development – Reduce trial timelines and optimize biomarker validation. ✅ Transforming immuno-oncology – Unlock next-gen personalized immunotherapies. ✅ Scalable, global impact – Making precision oncology more accessible & clinically relevant. Bringing precision to where it matters most – real-world patient care. WHO WE WORK WITH Cancer Clinics & Research Centers – Advance breakthrough trials & personalized treatment pathways. Pharmaceutical & Biotech Companies – Accelerate drug R&D, patient stratification, and regulatory approvals. Investors & Partners – Drive global expansion and impact in precision medicine. We are seeking visionary partners to push the boundaries of precision oncology. Let’s collaborate to redefine cancer care. Visit our website: www.solid-io.com Partner with us: noora.hujala@solid-io.com Based in Helsinki, Finland | Collaborating Globally

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Entry

Manager

Employees by Department

Solid IO has 4 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore Solid IO's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2025-03-24	2	$841,600

Funding Insights

$841,600

Total funding amount

$841,600

Most recent funding amount

Number of funding rounds

Frequently asked questions

Solid IO is located in Solid Immuno-Oncology Oy, C/O Terkko Health Hub, FI.

Solid IO generates an estimated annual revenue of $684,440. This revenue figure reflects the company's market position and business performance in its industry.

Solid IO has an estimated valuation of $2,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Solid IO was founded in 2025, making it 1 years old. The company has established itself as a significant player in its industry over this time.

Solid IO has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Solid IO has raised a total of $841,600 across 1 funding rounds. This investment has helped the company grow and expand its operations.